University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...
Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...
Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase ...
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...